Lupus
Theoretical Foundation in Nursing Practice
Title: The disease i choose is Lupus
Number of sources: 4
Paper instructions:
Instructions
For this assignment you will complete a Basic Concept Map based on an exemplar condition, disorder, or disease process. The Concept Map will include the following:
Pathophysiology
In your own words, in about 3-5 sentences.
Must cite resource
Assessment Data
Subjective
Objective
3-Part Nursing Diagnosis Statement
Two nursing diagnosis/priority problems
Should be prioritized based on most urgent/important
Short Term Goal
One goal for each nursing diagnosis/priority problem.
Interventions with Rationale
Must cite rationale
Assessment
Template
Lupus is a body disorder where the immune system starts to attack body tissues located in various parts of the body. The major pathophysiological change with lupus disorder is that inflammation starts to occur in various parts of the body such as the heart, kidneys, and brain (Kotliarov, Sparks, Martins, Mulè, Lu, Goswami & Tsang, 2020). Another pathophysiological change as a result of lupus is that it creates thick and red skin patches with distinct edges. Other possible physiological changes that may occur are hair loss, mouth ulcers, and skin lesions.
My subjective assessment data concerning lupus disorder is that human genes influence how immune systems work. The reason why I consider human genes to affect the effectiveness of the immune system is that a person can inherit lupus disorder from parents (Keeling, Alabdurubalnabi, Avina-Zubieta, Barr, Bergeron, Bernatsky & Santesso, 2018). The second subjective assessment concerning lupus disorder is that the external environment conditions can trigger lupus disorder. The third assessment concerning lupus disorder is that medical practitioners can do away with lupus disorder when they discover it at an early stage.
One objective assessment concerning lupus disorder is that pathophysiological changes as a result of lupus disorder vary from one person to another. The second objective assessment concerning lupus disorder is that patients may confuse the lupus symptoms with symptoms of other illnesses without their knowledge (Keeling, Alabdurubalnabi, Avina-Zubieta, Barr, Bergeron, Bernatsky & Santesso, 2018). The third objective assessment is that lupus disorder may interfere with the normal functioning of the blood cells and vessels.
Medical practitioners have not yet developed a direct diagnostic procedure for lupus disorder. For this case, the first nursing diagnosis is combining urine tests, blood tests, and other physical examinations that will guide the diagnosis (Samotij & Reich, 2019). The short-term goal for this first diagnosis is to determine whether a patient has any traces of lupus disorder. The diagnostic procedure for this first test will begin by obtaining some blood and urine samples from the patient. The next step will be examining the patient’s body. The second nursing diagnosis will be the antinuclear antibody test that will trace antibodies that can trigger lupus disorder (Samotij & Reich, 2019). The short-term goal of this test is to determine ways of keeping the patient safe from risk factors that can result in lupus disorder. The procedure for this test entails taking blood samples from the patient and then screening to trace antibodies that can trigger lupus.
The nursing intervention for the first diagnosis if the patient has lupus symptoms is offering medical treatment to reduce the severity and preventing flares. The second intervention will entail fixing the immune system to prevent lupus from reoccurring. The nursing intervention for the second diagnosis is enhancing the immune system by making it healthy so that it doesn’t affect any body tissues of the patient. Another intervention will be guiding the patient on how to live a healthy life by staying away from risk factors that may trigger lupus.
References
Bakula, M., Čikeš, N., & Anić, B. (2019). Validation of the new classification criteria for systemic lupus erythematosus on a patient cohort from a national referral center: a retrospective study. Croatian medical journal, 60(4), 333-344.
Keeling, S. O., Alabdurubalnabi, Z., Avina-Zubieta, A., Barr, S., Bergeron, L., Bernatsky, S., … & Santesso, N. (2018). Canadian Rheumatology Association recommendations for the assessment and monitoring of systemic lupus erythematosus. The Journal of rheumatology, 45(10), 1426-1439.
Kotliarov, Y., Sparks, R., Martins, A. J., Mulè, M. P., Lu, Y., Goswami, M., … & Tsang, J. S. (2020). Broad immune activation underlies shared set point signatures for vaccine responsiveness in healthy individuals and disease activity in patients with lupus. Nature medicine, 26(4), 618-629.
Samotij, D., & Reich, A. (2019). Biologics in the treatment of lupus erythematosus: a critical literature review. BioMed research international, 2019.
